Blogs

30
Apr 2024

Navigating Oncology Drug Packaging Challenges with CCIT

Navigating Oncology Drug Packaging Challenges with CCIT

Oncology drugs pose significant challenges in packaging due to their potency, toxicity, and the risks of human and environmental contamination. Ensuring sterility is crucial for certain administration methods, while also safeguarding against potential harm to handlers and manufacturers. Improper packaging or material selection can result in weak seals, breaches in sterility, and product leakage, compromising both safety and efficacy.

Early-stage package development and ongoing in-process packaging checks are essential measures to guarantee effective packaging. While various tests like Extractables and Leachables (E&L) and Transportation tests contribute to product safety, they may not always detect leaks in packaging. Therefore, Container Closure Integrity Testing (CCIT) emerges as a robust and indispensable method for identifying poor packaging performance and guiding package development.

CCIT offers a comprehensive approach to assessing package integrity across a range of formats commonly used for oncology drugs, including rigid parenterals, bottles, IV bags, and blister packs. Each packaging format presents unique challenges, and CCIT offers tailored test methods for each, ensuring thorough evaluation and reliable results.

Blister packs, often utilized for oncology drugs, typically consist of a low headspace formed poly or foil tray with a flexible lid stock. For products packaged in aluminum cold form blisters, helium leak detection is employed for ultra-high sensitivity, capable of detecting leaks down to 1E-10 mBar/l*s. Additionally, force decay testing provides inline applications with sensitivity down to 15 microns, ensuring stringent quality control measures.

Rigid parenterals, another common packaging option, offer flexibility in testing methods, including Vacuum Decay and MicroCurrent High Voltage Leak Detection (HVLD). These methods can detect leaks down to 1 micron, both inline and offline, providing comprehensive assurance of package integrity.

In conclusion, addressing the unique packaging challenges of oncology drugs requires a multifaceted approach, with CCIT playing a pivotal role in ensuring product safety, efficacy, and regulatory compliance. By leveraging advanced testing methodologies tailored to specific packaging formats, manufacturers can mitigate risks and uphold the highest standards of quality assurance in oncology drug packaging.

Readmore...
CCIT, drug packaging, oncology, CCI, Container closure integrity testing, vacuum decay, HVLD
5287

Popular Blogs

Tags

How to Leak Test High Risk Medical Device Packages

Jan 25, 2022   |   9243

Medical device leak testing is considered a critical step in ensuring package integrity primarily due to its sensitive nature. Leaks in the device can cause serious health risks to the patients and result in huge financial losses to the manufacturer. PTI's Seal-Scan technology is a non-destructive seal quality inspection technique for high risk pharmaceuticals and medical devices.

A Closer Look at PTI's Advanced Testing Services

Jun 27, 2024   |   7786

PTI offers advanced lab testing services across industries, safeguarding product integrity, safety, and regulatory adherence. Their expertise spans feasibility studies, test method development, stability testing, recall & batch release, and helium testing, all conducted by qualified professionals using advanced technologies.

Helium Leak Testing for Pharmaceuticals - PTI Offers Unmatched Solutions

Jul 15, 2024   |   7045

PTI offers unparalleled helium leak testing solutions for pharmaceutical packaging integrity. Our advanced services ensure high sensitivity and non-destructive testing, safeguarding product sterility and efficacy.

Decoding USP Standards - An In-Depth Look at USP <382>

Aug 02, 2024   |   6861

USP <382> sets new standards for assessing the functionality of elastomeric components in injectable drug packaging, emphasizing comprehensive container closure integrity testing to ensure safety and efficacy. Compliance by December 2025 is critical for pharmaceutical companies to maintain robust and reliable packaging systems.

Container Closure Integrity Testing (CCIT) - An Ideal Solution for the Pharmaceutical Industry

Sep 01, 2020   |   6600

Container Closure Integrity Testing is a method of leak detection using a non-destructive packaging inspection system to prevent possible contamination in pharmaceutical products.
ptiusa

Nuestras tecnologías cumplen con las normas de la ASTM y con otras normas reguladoras.

Packaging Technologies & Inspection

PTI ofrece sistemas de inspección para realizar pruebas de fugas en envases y pruebas de integridad del sellado y del cierre en contenedores (CCIT). Nuestras tecnologías excluyen la subjetividad de las pruebas en envases y usan métodos de prueba que cumplen con las normas de la ASTM. Las tecnologías de inspección de PTI son métodos de prueba deterministas que producen datos de resultados de la prueba cuantitativos. Nos especializamos en ofrecer la solución completa, incluidos el desarrollo del método de prueba y la validación de los equipos.

Contacto

 

Packaging Technologies & Inspection

PTI ofrece sistemas de inspección para realizar pruebas de fugas en envases y pruebas de integridad del sellado y del cierre en contenedores (CCIT). Nuestras tecnologías excluyen la subjetividad de las pruebas en envases y usan métodos de prueba que cumplen con las normas de la ASTM. Las tecnologías de inspección de PTI son métodos de prueba deterministas que producen datos de resultados de la prueba cuantitativos. Nos especializamos en ofrecer la solución completa, incluidos el desarrollo del método de prueba y la validación de los equipos.

ptiusa

Nuestras tecnologías cumplen con las normas de la ASTM y con otras normas reguladoras.

Contacto

 
Popup